{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T04:10:58Z","timestamp":1748059858631,"version":"3.41.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Peripheral artery disease (PAD) is a progressive, systemic atherosclerotic disease that is associated with an increased risk of coronary artery disease, cerebrovascular disease, and critical limb ischemia (CLI). CLI represents the most severe stage of PAD, characterized by progressive endothelial dysfunction and arterial narrowing. We hypothesized that the incidence of CLI and PAD would increase over the study period and that the rates of in-hospital mortality and major amputations among patients admitted with CLI would rise correspondingly.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We utilized the National Inpatient Sample database from 2016 to 2021 using the International Classification of Disease, Tenth Edition, Clinical Modification codes. Patients with primary or secondary diagnoses of PAD were initially selected, and subsequently hospitalization with CLI was appropriately identified. The Cochran Armitage test was used to describe the trend of outcomes across the years. All statistical analyses were conducted using the software Stata version 17.0.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>From 2016 to 2021, there were 2,930,639 admissions for CLI. Up to 65% of these patients were over the age of 60, and 35.8% of these patients were women. Most of these individuals were white (64.7%), followed by African Americans (15.8%) and Hispanics (12.6%). In-hospital mortality rates varied by revascularization method, with hybrid revascularization showing the highest rate at 2.6%, followed by endovascular revascularization at 1.8%, and surgical revascularization at 1.6%. Additionally, hospitalization costs were highest for patients undergoing hybrid revascularization ($46,257 \u00b1 $36,417), compared with endovascular ($36,924 \u00b1 $27,945) and surgical revascularization ($35,672 \u00b1 $27,127). Endovascular revascularization rates seemed to increase while surgical revascularization rates decreased during this time period.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>PAD is a progressive, systemic atherosclerotic disease that is associated with an increased risk of coronary artery disease, cerebrovascular disease, and CLI. Our data showed that the rates of PAD and CLI hospitalizations have remained relatively stable from 2016 to 2021, but there seems to be a trend toward doing more revascularization via an endovascular approach as compared to a surgical approach.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/hpc.0000000000000377","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T19:00:26Z","timestamp":1727377226000},"page":"e0377","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Temporal Trends and Outcomes of Peripheral Artery Disease and Critical Limb Ischemia in the United States"],"prefix":"10.1097","volume":"24","author":[{"given":"Chayakrit","family":"Krittanawong","sequence":"first","affiliation":[{"name":"Cardiology Division, NYU Langone Health and NYU School of Medicine, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Imoh","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Baylor College of Medicine, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song Peng","family":"Ang","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Rutgers Health\/Community Medical Center, NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf Kamran","family":"Qadeer","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Henry Ford Hospital, Detroit, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafeez Ul Hassan","family":"Virk","sequence":"additional","affiliation":[{"name":"Harrington Heart & Vascular Institute, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboob","family":"Alam","sequence":"additional","affiliation":[{"name":"The Texas Heart Institute, Baylor College of Medicine, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl J","family":"Lavie","sequence":"additional","affiliation":[{"name":"John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raman","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Medicine\/Cardiology, Icahn School of Medicine at Mount Sinai, The Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Jos\u00e9e Henry R. Kravis Cardiovascular Health Center, Icahn School of Medicine at the Mount Sinai Hospital, Mount Sinai Heart, New York, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"R1-20250523","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.atherosclerosis.2018.05.033","article-title":"Update on peripheral artery disease: epidemiology and evidence-based facts.","volume":"275","author":"Shu","year":"2018","journal-title":"Atherosclerosis"},{"key":"R2-20250523","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.amjmed.2019.04.043","article-title":"Peripheral artery disease: past, present, and future.","volume":"132","author":"Campia","year":"2019","journal-title":"Am J Med"},{"key":"R3-20250523","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jvs.2014.03.290","article-title":"Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population.","volume":"60","author":"Nehler","year":"2014","journal-title":"J Vasc Surg"},{"key":"R4-20250523","doi-asserted-by":"crossref","first-page":"e007539","DOI":"10.1161\/CIRCOUTCOMES.120.007539","article-title":"Contemporary trends in hospital admissions and outcomes in patients with critical limb ischemia: an analysis from the national inpatient sample database.","volume":"14","author":"Anantha-Narayanan","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R5-20250523","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jacc.2016.02.040","article-title":"Nationwide trends of hospital admission and outcomes among critical limb ischemia patients: from 2003-2011.","volume":"67","author":"Agarwal","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R7-20250523","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition.","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"R8-20250523","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"R9-20250523","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/tobaccocontrol-2021-056535","article-title":"Evolution of the global smoking epidemic over the past half century: strengthening the evidence base for policy action.","volume":"31","author":"Dai","year":"2022","journal-title":"Tob Control"},{"key":"R10-20250523","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.jacc.2011.08.023","article-title":"2011 ACCF\/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"58","author":"Rooke","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R11-20250523","doi-asserted-by":"crossref","first-page":"351","DOI":"10.7326\/M17-3203","article-title":"Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American College of Cardiology\/American Heart Association Hypertension Guideline.","volume":"168","author":"Carey","year":"2018","journal-title":"Ann Intern Med"},{"key":"R12-20250523","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3803\/EnM.2022.105","article-title":"Recent updates to clinical practice guidelines for diabetes mellitus.","volume":"37","author":"Yu","year":"2022","journal-title":"Endocrinol Metab (Seoul)"},{"key":"R13-20250523","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.numecd.2022.11.020","article-title":"Mortality rate related to peripheral arterial disease: a retrospective analysis of epidemiological data (years 2008-2019).","volume":"33","author":"Voci","year":"2023","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R14-20250523","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1177\/2047487319899626","article-title":"Trends in peripheral arterial disease incidence and mortality in EU15+ countries 1990-2017.","volume":"28","author":"Goodall","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"R15-20250523","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/1538574420928158","article-title":"Atherosclerotic peripheral artery disease in the United States: gender and ethnic variation in a multiple cause-of-death analysis.","volume":"54","author":"Nwancha","year":"2020","journal-title":"Vasc Endovascular Surg"},{"key":"R16-20250523","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/ccd.26883","article-title":"Temporal trends in peripheral arterial interventions: observations from the blue cross blue shield of Michigan cardiovascular consortium (BMC2 PVI).","volume":"89","author":"Thomas","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"R17-20250523","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/SLA.0000000000001676","article-title":"Endovascular versus open revascularization for peripheral arterial disease.","volume":"265","author":"Wiseman","year":"2017","journal-title":"Ann Surg"},{"key":"R18-20250523","doi-asserted-by":"crossref","first-page":"e008150","DOI":"10.1161\/CIRCINTERVENTIONS.119.008150","article-title":"Endovascular versus surgical revascularization for acute limb ischemia: a propensity-score matched analysis.","volume":"13","author":"Kolte","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"R19-20250523","doi-asserted-by":"crossref","first-page":"e2227746","DOI":"10.1001\/jamanetworkopen.2022.27746","article-title":"Comparison of 6-month outcomes of endovascular vs surgical revascularization for patients with critical limb ischemia.","volume":"5","author":"Majmundar","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R20-20250523","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.avsg.2019.06.039","article-title":"Comparison between endovascular and open surgery for the treatment of peripheral artery diseases: a meta-analysis.","volume":"62","author":"Tang","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"R21-20250523","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/eurheartj\/ehab116","article-title":"Long-term outcomes following endovascular and surgical revascularization for peripheral artery disease: a propensity score-matched analysis.","volume":"43","author":"Parvar","year":"2021","journal-title":"Eur Heart J"},{"key":"R22-20250523","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","article-title":"Surgery or endovascular therapy for chronic limb-threatening ischemia.","volume":"387","author":"Farber","year":"2022","journal-title":"N Engl J Med"},{"key":"R23-20250523","first-page":"1313","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"149","year":"2024","journal-title":"J Am Coll Cardiol"}],"container-title":["Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T14:08:22Z","timestamp":1748009302000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/hpc.0000000000000377","relation":{},"ISSN":["1535-2811"],"issn-type":[{"type":"electronic","value":"1535-2811"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}